Lidocaína Grindeks

Lidocaine Hydrochloride, the active ingredient in Lidocaína Grindeks, is a local anesthetic presented as a sterile solution for epidural, intravenous and subcutaneous use. It provides rapid, reversible loss of sensation for surgical procedures, pain management and diagnostic interventions in adult patients.

GNH USA supplies Lidocaína Grindeks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, clinics and surgical centres worldwide. The company adheres to EU GMP standards and offers reliable logistics to meet global demand. All shipments are handled with appropriate temperature control and documentation.

Lidocaine Hydrochloride is used in the local anesthesia and analgesia pathway to provide targeted nerve blockade.

- Local anesthesia: Enables rapid loss of sensation for minor surgical or diagnostic procedures. - Epidural analgesia: Provides continuous pain relief during labor or postoperative recovery. - Intravenous regional anesthesia (Bier block): Allows temporary anesthesia of a limb for short surgical interventions.

Lidocaine may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Tingling or numbness at the injection site. - Mild dizziness or light‑headedness. - Nausea.

Serious or Rare Side Effects: - Cardiovascular arrhythmia or collapse. - Central nervous system seizures. - Severe allergic reaction (anaphylaxis).

When using Lidocaína Grindeks, clinicians should observe several safety measures.

- Patient assessment: Evaluate cardiac and hepatic function before administration. - Dose calculation: Adjust dose for elderly or patients with liver impairment. - Monitoring: Observe for signs of CNS toxicity during and after injection. - Contraindications: Avoid use in patients with known hypersensitivity to amide‑type local anesthetics. - Drug interactions: Use caution with class I antiarrhythmics and other sodium channel blockers. - Store below 25°C: Keep in original container, protect from moisture and light.

Lidocaine can interact with several medicines; awareness of the interaction level helps guide safe use.

Major Interactions (Avoid): - Class I antiarrhythmic agents (e.g., quinidine, procainamide): may cause profound cardiotoxicity. - Other local anesthetics: additive toxicity risk. - CYP3A4 inhibitors (e.g., ketoconazole): increase plasma lidocaine levels.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may enhance CNS depression. - Diuretics (e.g., furosemide): may reduce plasma protein binding. - General anesthetics (e.g., propofol): may potentiate hypotension.